| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0078 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |